PTHr pepducins (Anchor Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePTHr pepducins (Anchor Therapeutics)
Drug Alias NameParathyroid Hormone Receptor-Modulating Pepducins (Anchor Therapeutics)
ClassificationBiologics
Mechanisms of ActionParathyroid hormone receptor modulators
TargetsParathyroid hormone receptor
Therapy Area/IndicationsEndocrine System DiseasesMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnchor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnchor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsEndocrine System DiseasesMetabolic Diseases

Other Information

ATC CodeN/A
Related LinksN/A